VANCOUVER, British Columbia, Aug. 22, 2017 (GLOBE NEWSWIRE) — Vanc Pharmaceuticals Inc. (“VANC“) announced today that it has filed and mailed its notice of meeting and management information circular (“Circular“) for its annual general and special shareholders’ meeting to be held on September 15, 2017 (the “Meeting“). At the Meeting, VANC is facing a proxy contest from “Union Venture Trading SA” (“Union“), a private BVI company, that, with only about 5% stated ownership of our shares, is looking to control 100% of our board. The VANC board believes that Union is not acting independently, but is controlled by Mahmoud S. […]